The role of LOX-1 and oxidative stress in the progressive renal disease.
| Project/Area Number |
14571015
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Kidney internal medicine
|
|---|
| Research Institution | The University of Tokyo |
|---|
Principal Investigator |
KANAME Shinya The University of Tokyo, Faculty of Medicine, Research Associate, 医学部附属病院, 助手 (60224581)
|
|---|
| Project Period (FY) |
2002 – 2003
|
| Project Status |
Completed (Fiscal Year 2003)
|
| Budget Amount *help |
¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2003: ¥1,300,000 (Direct Cost: ¥1,300,000)
Fiscal Year 2002: ¥2,200,000 (Direct Cost: ¥2,200,000)
|
|---|
| Keywords | LOX-1 / oxidative stress / 5 / 6腎摘ラット |
|---|
| Research Abstract |
In this study, we investigated the LOX-1 expression 1in chronic renal failure model rats. 6 weeks after 5/6 nephrectomy, renal LOX-1 mRNA expression was markedly increased compared with control, which accompanied by elevation of blood pressure and impaired renal function. Immunohistochemical analysis showed that LOX-1 was widely expressed in the interstitial cells, although there was almost no staining in the glomeruli and tubules. Moreover, AT1 antagonist candesartan significantly suppressed the renal LOX-1 expression. These results suggest that enhanced renal expression of LOX-1 might play a role in the progression of chronic renal failure in rats.
|
Report
(3 results)
Research Products
(4 results)
